Related references
Note: Only part of the references are listed.Prediabetes and the risk of heart failure: A meta-analysis
Xiaoyan Cai et al.
DIABETES OBESITY & METABOLISM (2021)
Association between prediabetes and adverse outcomes in heart failure
Linlin Mai et al.
DIABETES OBESITY & METABOLISM (2021)
Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus
Jiandi Wu et al.
CIRCULATION-HEART FAILURE (2020)
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis
Xiaoyan Cai et al.
BMJ-British Medical Journal (2020)
Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic review
S. S. Zghebi et al.
DIABETIC MEDICINE (2019)
Visit-to-Visit Variability of Hemoglobin A1c in People Without Diabetes and Risk of Major Adverse Cardiovascular Events and All-Cause Mortality
Jonas Ghouse et al.
DIABETES CARE (2019)
The Screening and Prevention of Diabetes Mellitus
Lisa C. Martinez et al.
PRIMARY CARE (2019)
Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes
Yifei Mo et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in individuals with type 1 diabetes: An observational study
Stuart S. Wightman et al.
DIABETES OBESITY & METABOLISM (2018)
Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
Sanjay Basu et al.
DIABETES CARE (2018)
Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study
Hsien-Tsai Chiu et al.
PLOS ONE (2017)
Vascular complications in diabetes: old messages, new thoughts
Josephine M. Forbes et al.
DIABETOLOGIA (2017)
Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes
J. C. Prentice et al.
DIABETIC MEDICINE (2016)
Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study
Eric Yuk Fai Wan et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Glucose variability, HbA1c and microvascular complications
Jan Skrha et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2016)
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
Catherine Gorst et al.
DIABETES CARE (2015)
Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)
Omid Fatemi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2014)
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
Yoichiro Hirakawa et al.
DIABETES CARE (2014)
Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study
Giuseppe Penno et al.
CARDIOVASCULAR DIABETOLOGY (2013)
HbA1c: A Review of Analytical and Clinical Aspects
Cas Weykamp
ANNALS OF LABORATORY MEDICINE (2013)
Baseline comparison of three health utility measures and the feeling thermometer among participants in the action to control cardiovascular risk in diabetes trial
Dennis W. Raisch et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes
Ryotaro Bouchi et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells
B. Schisano et al.
DIABETOLOGIA (2011)
Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes
Richard J. MacIsaac et al.
HEART LUNG AND CIRCULATION (2011)
A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
Johan Waden et al.
DIABETES (2009)
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients
Antonio Ceriello et al.
DIABETES (2008)
Vascular disease and diabetes: is hypoglycaemia an aggravating factor?
Rohana J. Wright et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods
John B. Buse
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
William C. Cushman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Glycemia treatment strategies in the action to control cardiovascular risk in diabetes (ACCORD) trial
Hertzel C. Gerstein et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
Connie Kingry et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations
WK Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)